Thymosin Alpha-1 – 5mg

Thymosin Alpha-1 (Tα1), also known as thymalfasin, is a naturally occurring N-terminally acetylated 28-amino-acid peptide derived from prothymosin alpha.

Its research history centres on the regulation and communication of innate and adaptive immune-cell populations, with particular attention to dendritic-cell function, Toll-like-receptor-associated signalling, cytokine regulation and T-cell-related responses.

Unlike peptides associated primarily with structural tissue biology, Thymosin Alpha-1 provides a research framework focused on immune signalling and cellular communication. Experimental studies have investigated its interactions with dendritic cells, macrophages, T lymphocytes and other immune-cell populations.

Mechanistic research has particularly examined Toll-like-receptor and MyD88-associated pathways together with downstream signalling involving p38 MAPK and NF-κB.

Pronoia Bio supplies Thymosin Alpha-1 – 5mg as a batch-tested research material with a minimum purity standard of ≥99%.

Product: Thymosin Alpha-1

Strength: 5mg

SKU: PB-TA1-5

Also known as: Thymosin α1 (Tα1), Thymalfasin

Peptide class: Synthetic N-terminally acetylated peptide

Parent framework: Prothymosin alpha-derived peptide

Peptide length: 28 amino acids

Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH

Sequence notation: Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN-OH

Research focus: Dendritic-cell biology, TLR-associated signalling, cytokine regulation and immune-cell communication

Purity: ≥99%

Form: Lyophilised solid

Documentation: Batch-specific COA & SDS available

Exact chemical form and other batch-dependent analytical characteristics should be confirmed against the current Certificate of Analysis.

Thymosin Alpha-1 – 5mg is supplied as batch-tested research material against Pronoia Bio’s minimum ≥99% purity standard.

Each batch is managed separately to maintain traceability between supplied material, Pronoia inventory and supporting documentation.

Batch-specific analytical information is provided through the relevant Certificate of Analysis, with the current COA treated as the authoritative reference for purity, supplied chemical form and other batch-dependent characteristics.

Supporting Safety Data Sheet documentation is also available for laboratory reference.

Peptide identity & endogenous framework

Thymosin Alpha-1 is a 28-amino-acid N-terminally acetylated peptide generated within the prothymosin-alpha biological framework.

Its defined sequence and endogenous origin have made it a longstanding experimental peptide for investigating cellular communication within immune and inflammatory signalling systems.

Dendritic-cell signalling

Dendritic cells form an important interface between innate sensing and adaptive immune responses. Experimental research has investigated Thymosin Alpha-1 in dendritic-cell maturation and cytokine production, providing a framework for studying peptide-associated changes in dendritic-cell behaviour and downstream immune-cell communication.

Toll-like-receptor & MyD88-associated pathways

Research models have associated Thymosin Alpha-1 with Toll-like-receptor signalling, including TLR2- and TLR9-associated pathways in dendritic-cell systems.

Downstream signalling investigated in these models includes the MyD88 adaptor pathway together with p38 MAPK and NF-κB-associated signalling.

These pathways make Thymosin Alpha-1 relevant to experimental investigation of pattern-recognition signalling and the interface between innate sensing and adaptive cellular responses.

Cytokine & immune-cell communication

Thymosin Alpha-1 research also extends to cytokine-regulatory networks and interactions involving T lymphocytes, macrophages, natural killer cells and other immune-cell populations.

Rather than representing a single-target compound, its research literature reflects a broader immunoregulatory signalling profile across multiple cellular systems.

Research interpretation

Thymosin Alpha-1 has an extensive preclinical and clinical research history, and pharmaceutical forms of thymalfasin have been studied or used in certain jurisdictions.

Those studies provide biological and mechanistic context but should not be interpreted as demonstrating equivalent effects for Pronoia Bio research material.

Store the lyophilised material under controlled conditions appropriate to the current batch documentation and protect from unnecessary heat, light and moisture.

Laboratories should minimise repeated temperature changes and maintain appropriate sample identification and inventory controls during storage and handling.

The current COA and SDS should take precedence for batch-specific storage and handling requirements.

Thymosin Alpha-1 – 5mg is supplied by Pronoia Bio within the United Kingdom using tracked delivery services.

Current availability, dispatch information and available delivery services are shown on the website and during checkout.

Thymosin Alpha-1 – 5mg is supplied exclusively for laboratory, analytical and experimental research.

It is not for human or veterinary use and is not intended for consumption, therapeutic application, diagnosis, treatment or administration.

Pronoia Bio does not provide dosage, administration or clinical-use guidance.